Use of in vivo-induced antigen technology for identification of Escherichia coli O157:H7 proteins expressed during human infection

Authors

Manohar John, Massachusetts General Hospital
Indira T. Kudva, Harvard Medical School
Robert W. Griffin, Massachusetts General Hospital
Allen W. Dodson, Massachusetts General Hospital
Bethany McManus, Massachusetts General Hospital
Bryan Krastins, Harvard Medical School
David Sarracino, Harvard Medical School
Ann Progulske-Fox, University of Florida
Jeffrey D. Hillman, University of Florida
Martin Handfield, University of Florida
Phillip I. Tarr, Washington University School of Medicine in St. Louis
Stephen B. Calderwood, Harvard Medical SchoolFollow

Journal

Infection and Immunology

Publication Date

2005

Volume

73

Issue

5

Inclusive Pages

2665-2679

Document Type

Open Access Publication

DOI

10.1128/IAI.73.5.2665-2679.2005

Rights and Permissions

Use of In Vivo-Induced Antigen Technology for Identification of Escherichia coli O157:H7 Proteins Expressed during Human Infection Manohar John, Indira T. Kudva, Robert W. Griffin, Allen W. Dodson, Bethany McManus, Bryan Krastins, David Sarracino, Ann Progulske-Fox, Jeffrey D. Hillman, Martin Handfield, Phillip I. Tarr, and Stephen B. Calderwood Infect. Immun. May 2005 73:5 2665-2679; doi:10.1128/IAI.73.5.2665-2679.2005

Recommended Citation

John, Manohar; Kudva, Indira T.; Griffin, Robert W.; Dodson, Allen W.; McManus, Bethany; Krastins, Bryan; Sarracino, David; Progulske-Fox, Ann; Hillman, Jeffrey D.; Handfield, Martin; Tarr, Phillip I.; and Calderwood, Stephen B., "Use of in vivo-induced antigen technology for identification of Escherichia coli O157:H7 proteins expressed during human infection." Infection and Immunology. 73, 5. 2665-2679. (2005).
https://digitalcommons.wustl.edu/open_access_pubs/2167